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An association between symptoms and residential mold growth has been consistently observed
in several countries, but the contribution of dust mites and bacterial endotoxins to this relation
has not been established. To address this issue, we studied a sample of 403 Canadian
elementary school children during the winter months. Reported mold growth was compared to
respiratory and nonspecific symptoms before and after adjusting for dust mite antigens and
bacterial endotoxin. A 12-50% relative increase in symptom prevalence was associated with
reported mold growth both before and after adjusting for subject characteristics, dust mite
antigens, and endotoxins. In conclusion, the association between residential fungal contamination
and symptoms is not confounded by dust mites or bacterial endotoxins or other known disease-
causing agents. Key words: bacteria, dust mites, epidemiology, fungus, health. - Environ Health
Perspect 107(suppl 3):481-483 (1999).
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Questionnaire-based studies from several
countries have consistently found an
increased prevalence ofrespiratory symptoms
in residents ofhomes reported to be damp or
moldy (1-5). The apparent explanation is
that airborne spores or mycelia are causing
illness through allergic or toxic mechanisms
(6,7). However, both dust mites and bacter-
ial endotoxins are known disease-causing
agents (8,9). Thus, mites and endotoxins are
plausible confounders of the mold-health
association; they may be associated with the
exposure of interest (fungus) and are risk
factors for disease (symptoms). Williamson
et al. (10) reported a positive association
between physician-diagnosed asthma and
objectively measured dampness but not
between asthma and mold growth seen by a
qualified surveyor. This raises the possibility
that dampness causes illness independent of
fungus, for example, by increasing the bur-
den ofdust mites or Gram negative bacterial
endotoxins, both ofwhich may be related to
water sources. A recent review ofnine popu-
lation-based cross-sectional studies with
objective fungal measurements similarly con-
cluded that future studies must address the
influence ofcopollutants such as endotoxins
and dust mites (11). This present study
investigates the influence ofdust mites and
bacterial endotoxins on the observed associa-
tion between reported fungal contamination
and symptoms.
Materials and Methods
StudyGroup
Families ofelementary school children in
Wallaceburg, Ontario, Canada were sent
letters ofintroduction and then telephoned.
Consenting families were consecutively
recruited until the target sample size of400
subjects was obtained. From each home,
the one child closest to 10 years ofage was
studied. The participation rate was low,
about 35%, but no differences were found
when the sample was compared to popula-
tion statistics obtained from a Provincial
health survey.
Organizaion ofthe DataCollection
Home visits occurred during the winter as
follows. The parent most knowledgeable
about the child's health was asked to com-
plete a questionnaire. Air samples from
both the main living area and the child's
bedroom were collected over a 14- to 20-hr
period at a flow of 1.7-2.0 L/min on endo-
toxin-free nucleopore filters. The following
day, during the second visit, the air sam-
plers were turned off, and a dust sample
was vacuumed from the child's mattress
and coverings (2 min) and the entire main
living area floor (10 min).
TheQuestionnaire
Exposure questions. The presence ofmold
growth was defined as a "yes" response to
both of the following questions: a) Have
you ever had mold or mildew growing on
any surface inside your present home? and
b) Did this occur in the past 12 months?
In a previous study, test-retest agreement
for this two-question combination was
87% [95% confidence interval (CI),
85-90%] with a corresponding Kappa
statistic of0.73 (95% CI 0.68-0.79) (12).
Health Questions. To reduce the
number of statistical comparisons and
probability oftype I errors, health questions
were summarized as follows:
GENERAL SYMPTOMS. In the past
month has this child experienced any of
the following: Headaches, muscle aches,
fever and chills, nausea, diarrhea, difficulty
concentrating, irritability?
IRRITATION. In the past month has this
child experienced any of the following:
itchy eyes, skin rash or itch, nose irritation?
COUGH OR WHEEZE. Does this child
usually cough during the night or first
thing in the morning? (or) Has this child
ever wheezed during the night in the past
12 months?
CHEST ILLNESS. During the past 12
months, did this child have any chest ill-
ness? (and) Did the child have more than
one such illness?
ASTHMA. Has the doctor ever said that
this child had asthma? (and) Does he/she
still have asthma? (or) Does he/she cur-
rently take medicine for asthma regularly
(usually everyday)?
BACTERIAL ENDOTOXIN. Air samples
from the bedroom and living area, and
dust samples from the bedroom were ana-
lyzed for endotoxin. Air filters were washed
in 8 ml ofpyrogen-free water for 60 min.
Two hundred milligrams of dust were
washed in 10 ml ofwater for 60 min. The
water extracts were submitted to a Limulus
amoebocyte lysate assay using a chro-
mogenic test kit (Associates of Cape Cod,
Woods Hole, MA) (13,14) in a kinetic
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assay on an MR 5000 Microplate reader
(Dynatech Laboratories, West Sussex,
UK). Samples were tested in duplicate in
96-well pyrogen-free plates along with a
blank (pyrogen-free sterile water). A stan-
dard curve was constructed from a control
standard endotoxin. Readings were consid-
ered acceptable when the log time to a
defined optical density versus log concen-
tration had an RI2 > 0.98. The detection
limit may be as low as 0.005 endotoxin
units per milliliter.
DUST MITE ANTIGENS. Immunoassays
using monoclonal antibodies for Der p 1
and Der f 1 were used to detect the pres-
ence ofDermatophagoidespteronyssinus and
Dermatophagoidesfarinae in the bedroom
dust samples. These were collected by
vacuuming the entire mattress and cover-
ings for 2 min using a Euroclean HEPA-
filtered UZ 930 vacuum with a cotton filter
(Cambridge, Ontario, Canada) attached at
the entry port. Analysis was performed by
The Department ofAllergy and Clinical
Immunology at Johns Hopkins University.
Results were based on the World Health
Organization international standard extract
"National Institute for Biological Standards
and Control 82/518" (15).
Results
Characteristics ofthe subjects are presented
in Table 1. Of note, parental history of
allergic disease was high and yet so was pet
ownership and environmental tobacco
smoke, the latter being higher in homes
where mold was reported to be absent.
Median values ofdust endotoxin and Der p
1 were higher in homes reporting mold
growth (Table 2). There was also a 12-50%
relative increase in symptom prevalence
associated with mold growth (Table 3). The
symptom-mold association was adjusted
using BMDP multivariate logistic regression
for all the characteristics ofthe subject and
family listed in Table 1. Only smoking
contributed to the model at p< 0.05.
Adjusted odds ratios (OR) remained above
1 for all symptoms except for asthma, and
CIs excluded 1 for general and irritative
symptoms (Table 4). The symptom-mold
association was then adjusted for all the
measures ofdust mite antigen and bacterial
endotoxins listed in Table 2. Only the living
area and bedroom Der p 1 contributed to
the model at p<0.05. Again, adjusted OR
values remained above 1 for all symptoms
except for asthma, and CIs excluded 1 for
general and irritative symptoms. Con-
trolling for all significant factors did not
change the adjusted associations further.
Table 1. Distribution of index child and family characteristics as a function of absence/presence of reported
mold/mildew in past 12 months.
Mold/mildewa
Child and family characteristics Absent Present
Child's age, mean years 9.8 10.0
Child's sex, female 54.1% 49.4%
Parental allergies, hayfever, asthma 43.8% 51.1%
Parental education, more than high school 57.9% 67.0%
Pets in home 57.5% 65.0%
Household smokersb 54.1% 42.0%
nvalues in the `absent" mold/mildew category vary from 202-208 across variables; nvalues in the "present" category vary from
176-180. bp<0.05,x2test.
Table 2. Median (25th, 75th percentiles) of endotoxins and dust mite antigens as a function of absence/presence
of reported mold/mildew in past 12 months.
Mold/mildewa
Environmental characteristics Absent Present
Endotoxins
Living area dust(eu/mg) 160(40, 890) 270(45, 835)
Bedroom air(eu/m3) 4.6(0.9, 21.8) 2.4(0.9, 14.3)
Living area air(eu/m3) 0.7 (0.0, 1.4) 0.7 (0.4, 1.1)
Dust mites
Bedroom Derf(ng/g) 923(194, 3582) 1173(289, 3943)
Living area Derf(ng/g) 642(201, 3377) 605 (173, 2939)
Bedroom Der p (ng/g)b 337(91, 1829) 627(114,4999)
Living area Der p (ng/g)b 211(60, 1120) 627(63, 3802)
eu, endotoxin units. 'nvalues in the "absent" mold/mildew category varyfrom 173-205 acrossvariables; nvalues in the "present"
categoryvaryfrom 154-178. hp<0.05, Mann-Whitney U-test.
Table3. Prevalence ofsymptoms as a function ofabsence/presence of reported mold/mildew in past 12 months.
Mold/mildewa
Prevalence of symptoms Absent Present
Generalb 66.3% 83.3%
lrritationb 72.6% 81.7%
Cough/wheezeb 26.2% 38.9%
Asthma 11.1% 14.4%
Chest illness 12.7% 18.9%
nvalues in the "absent" mold/mildew category vary from 183-208 across variables; nvalues in the "present' category vary from
162-180. bp<0.05, X2 test.
Table 4. Unadjusted and adjusted odds ratios for the association between symptom and ever mold or mildew con-
trolling for selected sets offactors.
Controlling for Controlling fordust Controlling for
Unadjusted subject characteristics mites and endotoxins all factorsa
Symptom OR 95% Cl OR 95% Cl OR 95% Cl OR 95% Cl
General 2.28 1.31-3.97 2.26 1.29-3.95 2.26 1.27-4.00 2.25 1.26-4.00
Irritation 1.92 1.10-3.35 1.80 1.03-3.16 1.93 1.09-3.42 1.81 1.02-3.24
Cough/wheeze 1.43 0.84-2.43 1.36 0.79-2.33 1.36 0.79-2.35 1.28 0.74-2.23
Asthma 1.04 0.50-2.17 0.96 0.46-2.00 0.98 0.46-2.08 0.91 0.42-1.95
Chest illness 1.54 0.79-3.01 1.51 0.77-2.95 1.55 0.78-3.08 1.51 0.76-3.02
"The presence ofsmokers and continuous measures of bedroom and living area Derp (ng/g) are included inthis set.
Discussion
Similar to previous studies, an association
between symptoms and residential fungal
growth was detected. The concern about
confounding was justified. Theoretically,
fungus, dust mites, and Gram-negative
bacteria may tend to coexist because of a
common need for available water sources.
Empirically we found that dust mites were
higher in the bedrooms and living areas
of houses with more reported mold.
Endotoxins were unrelated to reported
mold, however, and the levels detectedwere
similar to those reported elsewhere (16,17).
However, accounting for these agents did
not change the magnitude of the ORs,
demonstrating the absence ofconfounding.
These findings indicate that it is more likely
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that the observed association between
symptoms and residential fungus is causal.
Further evidence will come from the devel-
opment of accurate measures of fungal
exposure and follow-up studies to deter-
mine the long-term effects ofchronic expo-
sure at the relatively low levels commonly
seen in residential settings.
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